Blazar, B R <br/><br/>
CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.  [electronic resource] 

 -  The Journal of clinical investigation  Aug 1998 
 - 473-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI3741  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD40 Antigens--immunology<br/>CD40 Ligand<br/>Cells, Cultured<br/>Graft vs Host Disease--immunology<br/>Immunosuppression Therapy<br/>Interleukin-2--pharmacology<br/>Isoantigens--immunology<br/>Lymphocyte Culture Test, Mixed<br/>Membrane Glycoproteins--antagonists & inhibitors<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, SCID<br/>Specific Pathogen-Free Organisms